TrialCephalalgia : an international journal of headache2018

Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine.

Egilius Lh Spierings et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.